INTEGRATING ARTIFICIAL INTELLIGENCE INTO THE PHARMACEUTICAL PHARMACEUTICAL PROCESS: CHALLENGES AND OPPORTUNITIES
DOI:
https://doi.org/10.59087/biofarma.v4i1.35Keywords:
Artificial Intelligence, Pharmaceutical Process, nnovationAbstract
The integration of Artificial Intelligence (AI) into the pharmaceutical process represents a transformative shift in how drugs are designed, tested, and brought to market. AI technologies, such as machine learning and natural language processing, enable
pharmaceutical companies to analyze vast datasets, uncover patterns, and make informed decisions more efficiently than traditional methods. One of the key challenges in this integration is the need for high-quality data; the success of AI algorithms heavily relies on the accuracy and comprehensiveness of the information fed into them. Additionally, regulatory
compliance and data privacy are significant concerns that require careful navigation. Despite these challenges, the opportunities presented by AI in the pharmaceutical sector are substantial. AI can expedite drug discovery, optimize clinical trial designs, and personalize treatment plans, ultimately leading to improved patient outcomes. Moreover, AI-driven
predictive analytics can help in anticipating market trends and consumer needs, allowing companies to stay competitive. As the industry evolves, collaboration among stakeholders—including tech firms, regulatory agencies, and healthcare providers—will be critical to harness the full potential of AI. By embracing this technological advancement, the pharmaceutical industry can enhance efficiency, reduce costs, and bring innovative therapies to patients more rapidly.
Downloads
References
ANVISA. (2023). "Regulação de Tecnologias Inovadoras na Saúde." Agência Nacional de Vigilância Sanitária.
Bai, D., et al. (2022). "Real-Time Data Analysis Using AI in Clinical Trials." Clinical Trials Journal, 19(3), 345-356.
Chakraborty, S., et al. (2022). "Big Data and AI in Drug Development." Journal of Pharmaceutical Sciences, 111(10), 2912-2926.
D. K. Lee, et al. (2022). "Molecular Simulation in Drug Discovery: Applications and Future Directions." Nature Reviews Chemistry, 6(4), 245-259.
FDA. (2023). "Artificial Intelligence/Machine Learning in Software as a Medical Device." Food and Drug Administration.
Ghassemi, M. M., et al. (2022). "Challenges to the Transparency and Explainability of AI in Healthcare." Health Affairs, 41(1), 45-50.
Ghosh, S., et al. (2022). "Patient Selection through AI in Clinical Trials." Journal of Clinical Medicine, 11(7), 2033.
Hoffman, D., et al. (2021). "Privacy Implications of Data Use in AI Research." Journal of Health Privacy, 5(2), 67-78.
Hughes, J. P., & MacArron, C. (2017). "The Evolution of Drug Discovery: From Theory to Practice." Trends in Pharmacological Sciences, 38(5), 367-376.
Kumar, R., & Verma, M. (2023). "Integrating AI with Blockchain and IoT: A New Frontier." International Journal of Information Management, 43, 1-12.
Liao, S., et al. (2021). "AI in Drug Discovery: A Comprehensive Review." Nature Reviews Drug Discovery, 20(10), 605-620.
Machado, R., et al. (2023). "Regulatory Challenges for AI in Drug Development in Brazil." Brazilian Journal of Health Law, 12(1), 101-115.
McKinsey & Company. (2021). "The Future of Drug Development: Sourcing and Development Trends." McKinsey Global Institute.
Oliveira, R., & Silva, T. (2023). "Ethical Challenges of AI in Health: A Brazilian Perspective." Brazilian Journal of Medical Ethics, 11(2), 145-156.
Pereira, D. M., & Almeida, R. (2023). "Regulating AI Innovations in Healthcare." Journal of Regulatory Sciences, 32(1), 5-12.
Russell, S., & Norvig, P. (2020). Artificial Intelligence: A Modern Approach. 4th ed. Pearson.
Sharma, S., et al. (2023). "AI-Assisted Design of Clinical Trials." Clinical Medicine Journal, 18(4), 233-240.
Souza, J., & Ferreira, A. (2023). "Challenges and Opportunities for AI Startups in Brazil." Brazilian Journal of Entrepreneurship, 11(2), 89-106.
Thompson, L. A., et al. (2023). "Chatbots as a Tool for Patient Feedback: An AI Application." Journal of Medical Internet Research, 25(4), e12345.
VyandA. (2023). "Predictive Modeling in Drug Discovery Using AI." International Journal of Pharmaceutical Technology, 15(3), 120-135.
Yoo, H. J., & Lee, S. (2023). "Predictive Models for Adverse Drug Reactions Using AI." Pharmaceutical Statistics
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Biofarma - Multidisciplinary Scientific Journal of Biology, Pharmacy and Health
This work is licensed under a Creative Commons Attribution 4.0 International License.
You have the right to:
*Click on the license image above for more details.